Public Charity

HEMOPHILIA SERVICES CONSORTIUM INC

Based in NEW YORK, NY, HEMOPHILIA SERVICES CONSORTIUM INC operates as a Public Charity. The organization reported $20.0M in revenue, $20.0M in expenses, $6.9M in total assets for fiscal year 2025.

EIN: 133875950 NEW YORK, NY Community Health Systems NTEE: E21 Latest filing: 2025

Total Revenue$20.0M

Total Expenses$20.0M

Total Assets$6.9M

Grant Records0

Filing Years2021–2025

Mission

TO ENHANCE AFFORDABLE CARE TO PEOPLE WITH HEMOPHILIA AND OTHER BLEEDING DISORDERS IN THE NEW YORK METROPOLITAN AREA BY HELPING TO ENSURE AN AVAILABLE SUPPLY OF BLOOD-CLOTTING CONCENTRATES AND OTHER MEDICATIONS FOR THE TREATMENT OF HEMOPHILIA AND OTHER BLOOD CLOTTING DISORDERS THROUGH THE PURCHASING AND DISPENSING, ON A COOPERATIVE, CENTRALIZED BASIS, OF SUCH MEDICATIONS TO ITS PATRON HOSPITALS, AND PROVIDING OTHER SERVICES PERMITTED TO BE PROVIDED BY CORPORATIONS EXEMPT FROM TAXATION UNDER SECTIONS 501(E) AND 501(C)(3) OF THE CODE.

Where $100 goes at Hemophilia Services Consortium Inc

How Hemophilia Services Consortium Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.

$98 Programs the work itself

$2 Management running the organization

$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $98 for programs

$98

To enhance affordable care to people with hemophilia and other bleeding disorders in the New York metropolitan area by helping to ensure an available supply of blood-clotting concentrates…

All program spending

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

Director Catherine Mcguinn

Director Christopher Fieger

Director Christopher Walsh

Director/ VP Colin Lahiff

Director Edward Rogoff

Director Helen Irving

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2025	$20.0M	$20.0M	$6.9M
2024	$21.2M	$21.2M	$7.5M
2023	$21.2M	$21.2M	$7.7M
2022	$20.6M	$20.6M	$5.9M
2021	$18.0M	$18.0M	$4.5M

Between 2021 and 2025, reported annual revenue grew from $18.0M to $20.0M (+11%), with total assets most recently reported at $6.9M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for HEMOPHILIA SERVICES CONSORTIUM INC

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports